Randomized trial of two versus four years of adjuvant tamoxifen (AT) for postmenopausal women with node positive breast cancer

被引：0

作者：

Gallen, M ^{[1
]}

Alonso, C ^{[1
]}

Ojeda, B ^{[1
]}

Viladiu, P ^{[1
]}

Beltran, M ^{[1
]}

Borras, J ^{[1
]}

Pelegri, A ^{[1
]}

Tusquets, I ^{[1
]}

Barnadas, A ^{[1
]}

Arcusa, A ^{[1
]}

Bastus, R ^{[1
]}

Balil, A ^{[1
]}

Batiste-Alentorn, E ^{[1
]}

Boleda, M ^{[1
]}

Badia, MA ^{[1
]}

Garau, I ^{[1
]}

Guash, I ^{[1
]}

机构：

[1] Hosp Mar, Barcelona, Spain

来源：

EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷

关键词：

D O I：

10.1016/S0959-8049(97)89318-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P101

引用

页码：S40 / S40

页数：1

共 50 条

[1] Randomized trial or adjuvant tamoxifen pour years vs two years in node positive breast cancer women.
Gallén, M
Alonso, C
Ojeda, B
Viladíu, P
Beltrán, W
Borrás, J
Tusquets, I
Arcusa, A
Barnadas, A
Bastús, R
Balil, A
Batiste-Alentorn, E
Guasch, I
Garau, I
Boleda, W
Badia, A
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S56 - S56
[2] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
Rutqvist, LE
Hatschek, T
Ryden, S
Bergh, J
Bengtsson, NO
Carstenssen, J
Nordenskjold, B
Wallgren, A
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) : 1543 - 1549
[3] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
Machin, D
Andersen, KW
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09): : 659 - 659
[4] A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF ADJUVANT TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE BREAST-CANCER
DEMBO, AJ
PRITCHARD, KI
MEAKIN, JW
BOYD, NF
AMBUS, U
EVANS, WK
SUTHERLAND, DJA
WILKINSON, RH
BASSETT, A
CAMPBELL, J
DEBOER, G
PATERSON, AHG
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (02): : 118 - 118
[5] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer - Response
Rutqvist, LE
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) : 659 - 660
[6] RANDOMIZED TRIAL OF ADJUVANT TAMOXIFEN IN NODE NEGATIVE POSTMENOPAUSAL BREAST-CANCER
RUTQVIST, LE
CEDERMARK, B
GLAS, U
JOHANSSON, H
ROTSTEIN, S
SKOOG, L
SOMELL, A
THEVE, T
WILKING, N
ASKERGREN, J
HJALMAR, ML
RINGBORG, U
ACTA ONCOLOGICA, 1992, 31 (02) : 265 - 270
[7] A RANDOMIZED TRIAL OF ADJUVANT AMINOGLUTETHIMIDE VERSUS PLACEBO IN POSTMENOPAUSAL PATIENTS WITH NODE POSITIVE BREAST-CANCER
JONES, AL
POWLES, TJ
COOMBES, RC
SMITH, IE
EASTON, D
BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 521 - 522
[8] Combining and sequencing adjuvant chemotherapy and tamoxifen in postmenopausal women with node-positive breast cancer
Leeper, Alexander
Dixon, J. Michael
WOMENS HEALTH, 2010, 6 (03) : 357 - 360
[9] RANDOMIZED TRIAL OF OBSERVATION VERSUS ADJUVANT THERAPY WITH CYCLOPHOSPHAMIDE, FLUOROURACIL, PREDNISONE WITH OR WITHOUT TAMOXIFEN FOLLOWING MASTECTOMY IN POSTMENOPAUSAL WOMEN WITH NODE-POSITIVE BREAST-CANCER
INGLE, JN
EVERSON, LK
WIEAND, HS
MARTIN, JK
VOTAVA, HJ
WOLD, LE
KROOK, JE
CULLINAN, SA
PAULSEN, JK
TWITO, DI
AHMANN, DL
FOLEY, JF
GREEN, SJ
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) : 1388 - 1396
[10] ADJUVANT TAMOXIFEN FOR PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN WITH ESTROGEN-RECEPTOR POSITIVE, NODE-POSITIVE BREAST-CANCER - A RANDOMIZED STUDY
GUNDERSEN, S
HANNISDAL, E
SOREIDE, JA
SKARSTEIN, A
VARHAUG, JE
BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (01) : 49 - 53

← 1 2 3 4 5 →